Evan Vitale

Accounting Professional

  • Evan Vitale
  • Contact Evan Vitale
  • Evan Vitale | Social Stream

Evan Vitale – The Latest in Venture Capital News

February 29, 2016 by Evan Vitale

By Evan Vitale

Here’s the latest in a variety of venture capital news.

According to “The Daily Startup” (via WSJ.com), the former security leads at Etsy have planned to publicly launch a new security product for teams that are quickly creating and shipping new software. Signal Sciences wants to provide a next-generation Web application firewall to developers who are creating and modifying applications multiple times a day. The Venice Beach, Calif., company grabbed a $9.7 million Series A funding round led by Index Ventures. Chief Executive Andrew Peterson, a former Etsy product manager, and Chief Security Officer Zane Lackey, Etsy’s former security lead, said they saw firsthand in their former roles that security information needs to be brought closer to the developers. “What was out there didn’t solve our problems,” Mr. Lackey said. “We have a deep empathy with our customers, we’ve lived the life that they live.”

Catch the rest of the story and others on WSJ here: on.wsj.com/1RqhQWX

Meanwhile, Reuters is reporting that venture capital groups invested $1.8 billion in commercial space startups in 2015, more than in the last 15 years combined, according to a report by aerospace consultants the Tauri Group. The full report is here: reut.rs/21Bh3qT

Cnet.com has reported that the US Labor Department concludes that Fenox Venture Capital illegally labeled 56 employees as interns. Now, the firm must pay them for three years of unpaid work. According to US law, specifically the Fair Labor Standards Act, companies are required to pay interns if they’re performing work that the company would hire someone to do, among other criteria. The full report is here: cnet.co/1TEeFy6

Venture capitalists are investing $75 million to launch Forty Seven Inc., a startup out of Stanford University, that has joined a race to defeat cancer by engaging the immune system in the fight against tumors. The full story is here: on.wsj.com/1S332zI

 

Filed Under: Evan Vitale, Venture Capital Tagged With: Evan Vitale, VC, Venture Capital, Venture Capital News

Recent Posts

  • Evan Vitale – The Rise of AI-Driven Due Diligence in Venture Capital
  • Evan Vitale – Navigating the Nuances: Unraveling the Intricacies of Private Equity Investments
  • Evan Vitale – Lawmakers Consider Tighter Controls on Private Equity in Healthcare After Hospital Cyberattack Fallout
  • Evan Vitale – Navigating the Evolving Landscape: Trends in Private Equity
  • Evan Vitale – Understanding the Dynamics of Real Estate Private Equity: A Comprehensive Overview

Evan's Other Websites

  • Professional Overview

RSS Latest US News

  • U.S. and China to Meet at Precarious Moment in Trade War
  • Breaking With Trump, Bacon Says He Won’t Follow His Party ‘Off the Cliff’
  • After His Trump Blowup, Musk May Be Out. But DOGE Is Just Getting Started.
  • Trump Jumps at the Chance for a Standoff in California Over Immigration
  • Deportee’s Lawyers Push for Contempt Proceedings Despite His Return
Tweets by @evanvitale
Twitter LinkedIn Facebook

Copyright © Evan Vitale · 2025